Inotiv, Inc. (NOTV)

Market Cap	21.94M
Revenue (ttm)	513.02M
Net Income (ttm)	-68.63M
Shares Out	34.37M
EPS (ttm)	-2.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	256,382
Open	0.6500
Previous Close	0.6478
Day's Range	0.6281 - 0.6599
52-Week Range	0.6100 - 5.6700
Beta	4.35
Analysts	Strong Buy
Price Target	3.00 (+375.44%)
Earnings Date	Feb 4, 2026

About NOTV

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 24, 1997
• Employees: 2,046
• Stock Exchange: NASDAQ
• Ticker Symbol: NOTV
• Website: https://www.inotiv.com

Financial Performance

In 2025, Inotiv's revenue was $513.02 million, an increase of 4.54% compared to the previous year's $490.74 million. Losses were -$68.63 million, -36.72% less than in 2024.

Analyst Summary

According to one analyst, the rating for NOTV stock is "Strong Buy" and the 12-month stock price target is $3.0.

Price Target

$3.0

(375.44% upside)

Analyst Consensus: Strong Buy